In calling for a complete overhaul of the way the government and society view long-term and post-acute care, a prominent group of geriatricians argued that the fractured response to COVID-19 in nursing homes may have caused more harm than good in...
In a special article in the July issue of JAMDA, leaders of AMDA – The Society for Post-Acute and Long-Term Care Medicine presented five keys to solving the COVID-19 crisis that relate to policy, collaboration, individualization, leadership, and...
One day after the federal government announced an ambitious plan to send point-of-care testing units for COVID-19 to all of the nation’s more than 15,000 nursing homes, leaders in the space expressed cautious optimism — while often emphasizing that...
Elder care homes across the US have been hard-hit by the virus - though the true extent of the severity remains unclear, months in. One thing is certain, however - Covid-19 has yet again highlighted long-standing flaws in America's health system...
JULY 2020 Karl Steinberg, MD, CMD The COVID-19 pandemic has been a nightmare for everyone associated with nursing facilities, with the most severe devastation landing on their residents. Outbreaks have wiped out a large swath of these precious,...
The first national organization to officially endorse the adoption of a national Physician Orders for Life-Sustaining Treatment (POLST) form has emerged. AMDA — The Society for Post-Acute and Long-Term Care Medicine announced Thursday that its board...
A nationally recognizable Physician’s Orders for Life-Sustaining Treatment form would give seriously ill or frail seniors the ability to communicate treatment preferences across care settings, according to the Society for Post-Acute and Long-Term...
Columbia, MD, and Washington, DC – AMDA – The Society for Post-Acute and Long-Term Care Medicine and National POLST are excited to announce that AMDA is the first national organization to formally endorse and support the adoption of a national POLST...
Reducing antipsychotic use in nursing homes is an ongoing priority for clinicians and their teams. A study in the June issue of JAMDA suggests that substantial improvements in the use of these drugs may be achieved through targeted, collaborative...
